Traws Pharma, Inc. Common Stock (TRAW) is a publicly traded Healthcare sector company. As of July 11, 2026, TRAW trades at $0.74 with a market cap of $10.28M and a P/E ratio of 0.93. TRAW moved +6.65% today. Year to date, TRAW is -32.74%; over the trailing twelve months it is -51.59%. Its 52-week range spans $0.64 to $19.44. Analyst consensus is neutral with an average price target of $1.00. Rallies surfaces TRAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover TRAW: 0 strong buy, 0 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $1.00.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $10.28M |
| P/E Ratio | 0.93 |
| EPS | $0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.44 |
| 52-Week Low | $0.64 |
| Volume | 119.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.79M |
| Net Income | $9.17M |
| Gross Margin | 0.00% |
2 analysts cover TRAW: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.00.